Know Cancer

or
forgot password

The National Lymphocare Study: An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma


Phase 4
18 Years
N/A
Open (Enrolling)
Both
Lymphoma, Non Hodgkin

Thank you

Trial Information

The National Lymphocare Study: An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma


Inclusion Criteria:



- Signed Informed Consent Form (unless the Institutional Review Board [IRB] has granted
a waiver of consent)

- Signed Authorization for the Use and Disclosure of Health Information document

- Age ≥18 years

- Histologic documentation of follicular NHL, according to Revised European-American
Lymphoma (REAL) classification system, as assessed by the local pathologist and
treating physician

- Initial diagnosis of follicular B-cell NHL within 6 months prior to enrollment

- Availability of cancer-specific historical data points in the patient's medical
records

Exclusion Criteria:

- Other indolent or histologic NHL subtypes

- Diagnosis of lymphoma > 6 months prior to enrollment

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Cinical Trials

Investigator Role:

Study Director

Investigator Affiliation:

Genentech

Authority:

United States: Institutional Review Board

Study ID:

U2963n

NCT ID:

NCT00097565

Start Date:

September 2004

Completion Date:

March 2014

Related Keywords:

  • Lymphoma, Non Hodgkin
  • Follicular Non-Hodgkin's Lymphoma
  • Lymphoma
  • Lymphoma, Follicular
  • Lymphoma, Non-Hodgkin

Name

Location